NASDAQ:CYTK
$38.63
(
1.77%
)
Friday, 2nd Jun 2023
Cytokinetics Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $36.20 | $41.24 | Friday, 2nd Jun 2023 CYTK stock ended at $38.63. This is 1.77% more than the trading day before Thursday, 1st Jun 2023. During the day the stock fluctuated 3.32% from a day low at $37.98 to a day high of $39.24. |
| 90 days | $32.96 | $41.74 | |
| 52 weeks | $32.96 | $55.80 |
Historical Cytokinetics prices
| Date | Open | High | Low | Close | Volume |
| 2023-06-02 | $38.56 | $39.24 | $37.98 | $38.63 | 649 590 |
| 2023-06-01 | $37.84 | $38.95 | $37.16 | $37.96 | 598 223 |
| 2023-05-31 | $38.11 | $39.02 | $37.14 | $37.69 | 645 289 |
| 2023-05-30 | $37.19 | $38.02 | $36.96 | $37.96 | 360 429 |
| 2023-05-26 | $37.38 | $37.92 | $37.06 | $37.36 | 362 431 |
| 2023-05-25 | $38.06 | $38.06 | $36.75 | $37.54 | 508 394 |
| 2023-05-24 | $38.79 | $38.79 | $37.82 | $38.14 | 649 393 |
| 2023-05-23 | $40.69 | $41.24 | $38.77 | $39.01 | 797 680 |
| 2023-05-22 | $39.16 | $40.99 | $39.16 | $40.75 | 874 102 |
| 2023-05-19 | $38.28 | $39.10 | $37.81 | $38.98 | 942 868 |
| 2023-05-18 | $37.80 | $37.88 | $36.66 | $37.58 | 378 640 |
| 2023-05-17 | $37.45 | $37.87 | $36.20 | $37.81 | 476 831 |
| 2023-05-16 | $38.29 | $38.50 | $36.59 | $37.23 | 713 614 |
| 2023-05-15 | $37.79 | $39.19 | $37.06 | $38.95 | 612 590 |
| 2023-05-12 | $37.74 | $37.97 | $36.96 | $37.64 | 535 934 |
| 2023-05-11 | $39.50 | $39.65 | $37.68 | $37.83 | 572 585 |
| 2023-05-10 | $38.84 | $39.39 | $38.50 | $39.23 | 500 083 |
| 2023-05-09 | $37.99 | $38.85 | $37.46 | $38.84 | 482 261 |
| 2023-05-08 | $39.61 | $39.73 | $37.90 | $38.41 | 577 708 |
| 2023-05-05 | $40.97 | $40.97 | $37.82 | $39.44 | 1 882 592 |
| 2023-05-04 | $40.01 | $40.20 | $38.40 | $39.29 | 974 299 |
| 2023-05-03 | $37.47 | $40.25 | $37.15 | $39.34 | 1 632 004 |
| 2023-05-02 | $37.77 | $38.05 | $36.78 | $37.31 | 941 262 |
| 2023-05-01 | $37.36 | $38.48 | $37.15 | $37.77 | 1 352 382 |
| 2023-04-28 | $37.87 | $38.50 | $37.27 | $37.40 | 965 952 |
| 2023-04-27 | $37.25 | $38.03 | $36.74 | $37.86 | 738 442 |
| 2023-04-26 | $37.94 | $38.64 | $36.84 | $37.14 | 423 153 |
| 2023-04-25 | $38.07 | $38.61 | $37.13 | $37.86 | 692 387 |
| 2023-04-24 | $38.24 | $38.40 | $37.15 | $38.32 | 498 954 |
| 2023-04-21 | $36.62 | $38.51 | $36.34 | $38.34 | 855 220 |
| 2023-04-20 | $37.61 | $37.73 | $36.20 | $36.59 | 580 230 |
| 2023-04-19 | $36.27 | $38.00 | $36.11 | $37.93 | 719 845 |
| 2023-04-18 | $36.92 | $37.51 | $36.42 | $36.80 | 1 274 459 |
| 2023-04-17 | $35.23 | $36.51 | $34.74 | $36.41 | 988 109 |
| 2023-04-14 | $35.91 | $36.18 | $34.50 | $34.78 | 551 300 |
| 2023-04-13 | $34.03 | $36.10 | $33.86 | $35.93 | 1 194 978 |
| 2023-04-12 | $35.68 | $35.91 | $33.88 | $34.05 | 795 554 |
| 2023-04-11 | $35.11 | $35.64 | $34.91 | $35.30 | 542 908 |
| 2023-04-10 | $36.15 | $36.42 | $34.61 | $34.99 | 1 655 857 |
| 2023-04-06 | $36.26 | $36.48 | $35.70 | $36.42 | 605 344 |
| 2023-04-05 | $36.21 | $36.98 | $35.84 | $36.16 | 667 787 |
| 2023-04-04 | $37.87 | $38.05 | $36.02 | $36.33 | 1 062 930 |
| 2023-04-03 | $35.15 | $37.76 | $34.60 | $37.71 | 1 556 111 |
| 2023-03-31 | $35.00 | $36.66 | $34.70 | $35.19 | 3 036 313 |
| 2023-03-30 | $35.47 | $35.70 | $34.16 | $34.21 | 838 239 |
| 2023-03-29 | $35.31 | $35.31 | $34.60 | $35.25 | 591 218 |
| 2023-03-28 | $34.36 | $35.60 | $33.98 | $34.98 | 803 723 |
| 2023-03-27 | $33.73 | $34.64 | $33.42 | $34.53 | 539 826 |
| 2023-03-24 | $33.37 | $33.64 | $32.96 | $33.36 | 720 685 |
| 2023-03-23 | $34.80 | $34.99 | $33.37 | $33.63 | 815 082 |
About Cytokinetics
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in pati... CYTK Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
